Hubei Qianjiang Pharmaceutical Co., Ltd. (hereinafter referred to as "Qianjiang Pharmaceutical") is located in Qianjiang, a star city in China known as the hometown of crayfish, and its headquarters is located in Qianjiang Pharmaceutical Biomedical Industrial Park, covering an area of 6.5438+0.4 million square meters. Founded in the 1970s, after more than 40 years of unremitting efforts, the company has developed into a comprehensive pharmaceutical enterprise integrating production, learning and research, and has a subsidiary company of bulk drug production-Hubei Jianqi Pharmaceutical Co., Ltd. The company has first-class production equipment, advanced production technology, strong scientific research force, excellent marketing team and high-quality staff, and has established a complete modern enterprise management system and process.
Qianjiang Pharmaceutical Co., Ltd., as a high-tech enterprise supported by the state and a national ophthalmic drug production base, insists on taking R&D as the guide, continuously invests in R&D, and has established close ties and cooperation with R&D institutions at home and abroad. 20 12, 10 signed an agreement with TNI company of the United States to develop anticancer drugs and actively integrated into the international market. The company now has 15 production line, and 123 products are freeze-dried agents and eye drops that have passed the national GMP certification. It has an annual production capacity of 80 million freeze-dried agents, 200 million small-volume injections, 200 million solid preparations (bags) and 200 million eye drops.
The company insists on taking ophthalmic drugs as the main feature and freeze-drying agents and bulk drugs as the main direction, and strives to steadily promote the development of traditional pharmaceutical preparations, build a production base for ophthalmic drugs and antiviral and anti-infective drugs, and at the same time focus on developing high-tech anti-tumor drugs, biomedicine and traditional Chinese medicine products to enhance the core competitiveness and profitability of enterprises.